COMP <GO>
CNC vs LLY // FORWARD P/E MULTIPLE
Centene Corporation (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: CNC 3
— LLY 11
▲ FORWARD P/E MULTIPLE LEADER: LLY
LAST: $68.45 (-0.25%) • MKT CAP: $33.97B
forward-pe
36.0x
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
forward-pe
26.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNC VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNC | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 8.10% | 83.64% | -75.54 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.00% | 32.36% | -63.36 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 36.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.72% | 2.30% | +10.42 | CNC | /fcf-yield <GO> |
| Operating Margin | -4.40% | 40.21% | -44.61 | LLY | /operating-margins <GO> |
| Net Profit Margin | -3.80% | 31.90% | -35.70 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 20.00% | 45.51% | -25.51 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.52 | 9.29 | -6.77 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.77% | -0.07 | CNC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.4 | 77.9 | -24.53 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.51 | +0.43 | CNC | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 36.0x | 26.3x | +9.75 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $33.97B | $1.33T | -$1.30T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNC REV | LLY REV | CNC GROSS % | LLY GROSS % | CNC FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $174.58B | $65.18B | 8.1% | 83.0% | $4.32B | $16.81B |
| FY 2024 | $145.50B | $45.04B | 11.7% | 81.3% | -$490.0M | $8.82B |
| FY 2023 | $140.09B | $34.12B | 44.0% | 79.3% | $1.75B | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNC // BETA 0.94
LLY // BETA 0.51